Our mission is to develop biosimilars, with scientific rigour and quality, to increase patients’ access to innovative medical treatments that help them improve their health.
At Syna our work is based on the following values:
Innovation: we are committed to the development and use of new biosimilar medications due to their high therapeutic value.
Attitude: we work rigorously, in a team, to find the most efficient way to reach the market.
Accessibility: we want to facilitate patient access to innovative, safe, effective and more sustainable treatments.
Sustainability: we help make National Health Systems around the world more sustainable, since biosimilars enable more innovative medicines to be available in more countries, and to more patients, at a lower cost than the original medication.